Global DVT Screening and Treatment Devices Market Research Report 2021

Deep Vein Thrombosis (DVT) is the formation of a blood clot within a deep vein, most commonly the legs.
Geographically, North America dominated the DVT screening and treatment devices market, with approximately half of the world’s procedures being done in the U.S. because of high medical reimbursement facilities, and technological advancement.

The global DVT Screening and Treatment Devices market was valued at US$ XX million in 2019 and is expected to reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.
This report focuses on DVT Screening and Treatment Devices volume and value at the global level, regional level and company level. From a global perspective, this report represents overall DVT Screening and Treatment Devices market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global DVT Screening and Treatment Devices Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Imaging Modalities
Intravascular Ultrasound
Venous Stenting
Compression Stockings
Others

Segment by Application
Hospitals and Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
F. Hoffmann-La Roche
Generex Biotechnology
Laboratorios Farmaceuticos Rovi
Pharmathen Pharmaceuticals
Bristol-Myers Squibb
3SBio
Wockhardt
Bayer
Pfizer